ISRCTN14231094进行中（未招募）未知
Evaluation of the effectiveness, pain and complications of computerized intraosseous anesthesia in comparison to inferior alveolar nerve block to anesthetize permanent lower first molars with molar incisor hypomineralization in children
适应症
试验速览
- 阶段
- 未知
- 状态
- 进行中（未招募）
- 入组人数
- 40
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 性别
- All
入选标准
- •1. Healthy children who don't suffer from any systemic disease
- •2. Children aged between 6 - 8 years
- •3. Children who need bilateral vital pulpotomy for mandibular first permanent molars with MIH.
- •4. Cooperative children who are classified as definitely positive according to Frankel
排除标准
- •1. The existence of any chronic or acute infection in the area of injection
- •2. Children who have taken any analgesics in the last two days before the anesthesia
- •3. Children who have allergy to amide type of anesthetic solutions.
- •4. Children who are contraindicated to lidocaine injection (who suffer from liver cirrhosis, hepatitis)
- •5. Children who are contraindicated to vasoconstrictors injection (who suffer from hypertension, myocardial infarction, angina pectoris)
- •6. Children who do not show cooperation during the procedure
研究者
相似试验
进行中（未招募）
不适用
The use of computerized anesthesia 'QuickSleeper 5' in children undergoing dental treatmentAnesthetizing primary molars in childrenOral HealthISRCTN60155644Damascus University52
已完成
不适用
Assessment of treatment efficacy and adverse effects of Microrelin in patient with prostate cancer.IRCT201109067457N4Pooyesh darou company40
招募中
3 期
Evaluation of the effect of fractional carbon dioxide laser with platelet-rich plasma in the treatment of burn scarsBurn scar.Scar conditions and fibrosis of skinL90.5IRCT20210515051307N2Skin and Stem cellResearch Center of Tehran University20
招募中
2 期
Comparison of the efficacy of botulinum toxin and triamcinolone in patients with hypertrophic scars treated with PDL laserHypertrophic scarIRCT20220121053776N1Iran University of Medical Sciences12
尚未招募
3 期
Evaluation of the effect of Medvac IVIg on PIDPrimary immunodeficiency disorder.D84.9 is a billable/specific ICD-10-CM code that can be used to indicate a diagnosis for reimbursement purposes.D84.9IRCT20101012004920N9Medvac BioPharma Company50